Earth Science Tech Inc. (OTC: ETST) reported fiscal year 2026 results for the year ended March 31, 2026, showcasing growth across key financial metrics as the company continues to operate its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate and consumer businesses. The company posted an 8% increase in revenue to $35.7 million, with gross profit rising 5% to $25.5 million. Net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST’s efforts to fully integrate the patient experience across telemedicine, pharmacy and fulfillment. The company operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Its healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The core of the company’s value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. This integration is designed to improve patient outcomes and operational efficiency, positioning ETST to capture growth in the evolving healthcare landscape. The results indicate that the company’s strategy is gaining traction, with revenue and profitability both trending upward.
For investors, the financial performance underscores ETST’s ability to execute on its integrated model. The company’s newsroom at https://nnw.fm/ETST provides ongoing updates. More information about Earth Science Tech is available at www.EarthScienceTech.com. The full article can be accessed at https://nnw.fm/u6mhk.
The implications of Earth Science Tech’s results extend beyond the company itself, reflecting broader trends in healthcare integration. By connecting telemedicine, pharmacy and fulfillment, ETST is addressing inefficiencies in the patient journey, potentially reducing costs and improving access to care. This model could serve as a blueprint for other companies seeking to streamline healthcare delivery. The growth in assets and profitability suggests that the market is rewarding such integration, and the company’s diversified holdings provide stability across economic cycles. As the healthcare industry continues to digitize and consolidate, ETST’s approach may become increasingly relevant, offering a comprehensive solution that benefits patients, providers and investors alike.
